Antithrombin-lowering in hemophilia: a closer look at fitusiran

Fitusiran Prophylaxis in Hemophilia With or Without Inhibitors

Antithrombin-lowering in hemophilia: a closer look at fitusiran - Research and Practice in Thrombosis and Haemostasis

Antithrombin-lowering in hemophilia: a closer look at fitusiran - ScienceDirect

Fitusiran Prophylaxis for Patients With Hemophilia A or B

HEMLIBRA: Potential Treatment for Hemophilia A Patients

Frontiers The Possible Non-Mutational Causes of FVIII Deficiency: Non-Coding RNAs and Acquired Hemophilia A

PDF] Laboratory monitoring of hemophilia A treatments: new challenges.

Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review - Verhagen - 2022 - Journal of Thrombosis and Haemostasis - Wiley Online Library

Fitusiran Prophylaxis in Hemophilia With or Without Inhibitors

Summer 2022 haemophilia trial update - European Pharmaceutical Review

Monthly injections of fitusiran found to reduce bleeds in patients with hemophilia A and B

Injectable drug may reduce bleeding in patients with hemophilia

Antithrombin-lowering in hemophilia: a closer look at fitusiran - ScienceDirect

Full article: Current and emerging biologics for the treatment of hemophilia

ALN-AT3SC - Creative Biolabs